Inscrição na biblioteca: Guest
Portal Digital Begell Biblioteca digital da Begell eBooks Diários Referências e Anais Coleções de pesquisa
Critical Reviews™ in Eukaryotic Gene Expression
Fator do impacto: 1.841 FI de cinco anos: 1.927 SJR: 0.627 SNIP: 0.516 CiteScore™: 1.96

ISSN Imprimir: 1045-4403
ISSN On-line: 2162-6502

Critical Reviews™ in Eukaryotic Gene Expression

DOI: 10.1615/CritRevEukaryotGeneExpr.v15.i2.20
pages 103-114

Rho Proteins in Cell Migration and Metastasis

Brian Titus
Department of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, VA
Martin A. Schwartz
Department of Microbiology, Department of Biomedical Engineering, University of Virginia, Charlottesville, VA
Dan Theodorescu
Department of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, VA; Department of Pharmacology, University of Colorado, Denver, Colorado; Department of Surgery (Urology), University of Colorado, Denver, Colorado; University of Colorado Comprehensive Cancer Center, Denver, Colorado

RESUMO

The ability of tumors to invade, colonize, and destroy distant organs was first recognized by Jean-Claude Recamier in 1829. He termed this phenomenon metastasis.1,2 Since it was first described, metastasis has been shown to be a complex multistep process.3 One important step is cell migration—a critical component of both cancer-cell invasion at the primary site (allowing cells to gain access to the vasculature) and for cells to penetrate the host tissue at distant sites.4 The aim of this review is to examine the fundamental role of migration in cancer progression and to discuss the role of the Rho family of small G proteins and their effectors in this process.


Articles with similar content:

Epigenetic/Genetic Mismatch: Using Transdifferentiation as a Potential Cancer Therapy to Exploit the Cell Type Specificity of Cancer
Critical Reviews™ in Oncogenesis, Vol.20, 2015, issue 5-6
Devasis Chatterjee, Andrew R. Mendelsohn, Jennifer L. Lei
Cell Death Induction in Cancer Therapy − Past, Present, and Future
Critical Reviews™ in Oncogenesis, Vol.21, 2016, issue 3-4
Marc-Eric Halatsch, Sebastian Hasslacher, Klaus-Michael Debatin, Oliver Brühl, Julia Zimmermann, Katia La Ferla-Brühl, Lisa Nonnenmacher, Timo Burster, Mike-Andrew Westhoff, Sara E. Barry, Markus D. Siegelin, Georg Karpel-Massler
Resistance to Cell Death and Its Modulation in Cancer Stem Cells
Critical Reviews™ in Oncogenesis, Vol.21, 2016, issue 3-4
Ahmad R. Safa
Prostate Cancer and Parasitism of the Bone Hematopoietic Stem Cell Niche
Critical Reviews™ in Eukaryotic Gene Expression, Vol.22, 2012, issue 2
Kenneth J. Pienta, Chunyan Yu, Yusuke Shiozawa, Evan T. Keller, Laurie K. McCauley, Russell S. Taichman
Cutting Eugenics Out of CRISPR-Cas9
Ethics in Biology, Engineering and Medicine: An International Journal, Vol.6, 2015, issue 3-4
Marya Pollack, Robert Pollack, Carolyn Brokowski